Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
small molecule |
| gptkbp:ATCCode |
C01EB
|
| gptkbp:CASNumber |
1801747-42-7
|
| gptkbp:clinicalTrialPhase |
Phase 3
|
| gptkbp:developedBy |
gptkb:Cytokinetics
|
| gptkbp:hasMolecularFormula |
C24H25FN6O2
|
| https://www.w3.org/2000/01/rdf-schema#label |
aficamten
|
| gptkbp:indication |
hypertrophic cardiomyopathy
|
| gptkbp:legalStatus |
investigational
|
| gptkbp:mechanismOfAction |
cardiac myosin inhibitor
|
| gptkbp:PubChem_CID |
gptkb:CHEMBL4297592
121489778 |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:UNII |
6Q1K1Q1K0E
|
| gptkbp:bfsParent |
gptkb:Cytokinetics
|
| gptkbp:bfsLayer |
6
|